
Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLOV · as of Jun 8, 2026
Key Statistics
Explore Clover Health Investments, Corp. Data
clov stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 11.1%
The CLOV analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $4.20, representing +7.14% upside from the current price of $3.92.
Competitors & Peers
clov competitorsStock Performance
Full HistoryAbout Clover Health Investments, Corp.
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Prefe…
what is clover health investments, corp. · clov stock overview · clover health investments, corp. company profile · who is clover health investments, corp. ceo · clov NASDAQ · clover health investments, corp. headquarters · clover health investments, corp. business segments
About Stock Overview & Key Data
Clover Health Investments, Corp. (CLOV) is a Healthcare company in the Medical - Healthcare Plans industry, listed on NASDAQ since Jun 12, 2020. As of the latest trading session, CLOV stock price is $3.92, with a market capitalization of $2.0B. The stock has returned +29.87% over the past 12 months and +64.68% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Clover Health Investments, Corp. stock is Hold, with an average 12-month price target of $4.20. In fiscal year 2025, Clover Health Investments, Corp. reported revenue of $1.9B and net income of -$85.5M. For detailed data — including Clover Health Investments, Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Clover Health Investments, Corp. (CLOV) stock price is $3.92. The stock is traded on NASDAQ under the ticker symbol CLOV. The 52-week range is $1.58 – $4.23.